- Report
- March 2025
- 141 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 171 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 74 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2023
- 256 Pages
Global
From €3249EUR$3,570USD£2,785GBP
The Newborn Genetic Testing market is a subset of the larger Genomics market. It involves the use of genetic testing to identify genetic disorders in newborns. This type of testing is typically done shortly after birth and can help detect conditions such as Down Syndrome, cystic fibrosis, and other genetic disorders. The results of the tests can help guide medical decisions and provide parents with information about their child's health.
The Newborn Genetic Testing market is growing as more parents opt for testing and as technology advances. The tests are becoming more accurate and cost-effective, making them more accessible to a wider range of parents. Additionally, the tests are becoming more comprehensive, allowing for the detection of a wider range of genetic disorders.
Some companies in the Newborn Genetic Testing market include Illumina, Natera, and Invitae. These companies provide a range of genetic testing services, including newborn genetic testing. Show Less Read more